NO20063937L - Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis - Google Patents

Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis

Info

Publication number: NO20063937L
Authority: NO; Norway
Prior art keywords: psoriasis; treatment; isoleucine; serine; composition
Prior art date: 2004-02-06

Application number

NO20063937A

Other languages

English (en)

Norwegian (no)

Inventor

Thomas Tallberg

Original Assignee

Helsingfors Institution For Bi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-06

Filing date

2006-09-04

Publication date

2006-09-04

2006-09-04 Application filed by Helsingfors Institution For Bi filed Critical Helsingfors Institution For Bi

2006-09-04 Publication of NO20063937L publication Critical patent/NO20063937L/no

Links

MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 title abstract 5
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title abstract 4
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 title abstract 3
201000004681 Psoriasis Diseases 0.000 title abstract 3
229930182844 L-isoleucine Natural products 0.000 title abstract 2
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title abstract 2
229960000304 folic acid Drugs 0.000 title abstract 2
235000019152 folic acid Nutrition 0.000 title abstract 2
239000011724 folic acid Substances 0.000 title abstract 2
229960000310 isoleucine Drugs 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
229960001153 serine Drugs 0.000 title abstract 2
239000011573 trace mineral Substances 0.000 title abstract 2
235000013619 trace mineral Nutrition 0.000 title abstract 2
239000011651 chromium Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000011669 selenium Substances 0.000 abstract 2
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
229940024606 amino acid Drugs 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
229910052804 chromium Inorganic materials 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
229910052711 selenium Inorganic materials 0.000 abstract 1
JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 abstract 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 abstract 1
229910052721 tungsten Inorganic materials 0.000 abstract 1
239000010937 tungsten Substances 0.000 abstract 1
LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20063937A 2004-02-06 2006-09-04 Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis NO20063937L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI20040180A FI121915B (fi)	2004-02-06	2004-02-06	Koostumus psoriasiksen hoitoon
PCT/FI2005/000075 WO2005074910A1 (en)	2004-02-06	2005-02-04	Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis

Publications (1)

Publication Number	Publication Date
NO20063937L true NO20063937L (no)	2006-09-04

Family

ID=31725662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063937A NO20063937L (no)	2004-02-06	2006-09-04	Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis

Country Status (17)

Country	Link
US (1)	US20070258892A1 (pt)
EP (1)	EP1718290B1 (pt)
JP (1)	JP4919812B2 (pt)
CN (1)	CN1917868B (pt)
AT (1)	ATE466576T1 (pt)
AU (1)	AU2005210181B2 (pt)
BR (1)	BRPI0507732A (pt)
CA (1)	CA2555328C (pt)
DE (1)	DE602005021062D1 (pt)
DK (1)	DK1718290T3 (pt)
ES (1)	ES2344510T3 (pt)
FI (1)	FI121915B (pt)
NO (1)	NO20063937L (pt)
PL (1)	PL1718290T3 (pt)
PT (1)	PT1718290E (pt)
RU (1)	RU2372899C2 (pt)
WO (1)	WO2005074910A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI122450B (fi) *	2007-12-28	2012-01-31	Neurofood Ab Oy	Koostumus steriilin inflammaation hoitoon
FR2947452B1 (fr)	2009-07-01	2012-04-20	Fabre Pierre Dermo Cosmetique	L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
CN101953846B (zh) *	2010-06-24	2011-12-28	攀枝花兴辰钒钛有限公司	一种药物组合物在制备治疗糖尿病的药物中的用途
EP2782566B1 (en)	2011-11-21	2021-01-06	The Institute for Ethnomedicine	L-serine as for use in treating neurodegenerative disorders
EP3586849A1 (en) *	2018-06-29	2020-01-01	Aprofol AG	Folate preparations
AU2020334128B2 (en) *	2019-08-21	2025-10-23	Brain Chemistry Labs	Compositions comprising a metal and L-serine, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL83775A (en) *	1987-09-04	1991-12-15	Dexter Chemical Corp	Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
DE3712986A1 (de) *	1987-04-16	1988-10-27	Marbert Gmbh	Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt
US5326569A (en) *	1992-12-23	1994-07-05	Abbott Laboratories	Medical foods for the nutritional support of child/adult metabolic diseases
CN1080131A (zh) *	1993-04-28	1994-01-05	王韵三	一种美容保健营养食品和制备方法
US5563132A (en) *	1994-06-21	1996-10-08	Bodaness; Richard S.	Two-step cancer treatment method
RU2071777C1 (ru) *	1995-01-13	1997-01-20	Тамара Васильевна Воробьева	Способ получения средства, обладающего противоопухолевой активностью
US6083293A (en) *	1997-02-24	2000-07-04	Bath; Virginia L.	Method for enhanced plant protein production and composition for use in the same
IT1299623B1 (it) *	1998-02-23	2000-03-24	Gen Topics Srl	Composizione per uso cosmetico o farmaceutico a base di acido lipoico e acido piruvico
WO1999055321A1 (en) *	1998-04-24	1999-11-04	Mitokor	Compounds and methods for treating mitochondria-associated diseases
GB0019327D0 (en) *	2000-08-08	2000-09-27	Buchanan Baillie Hamilton Paul	Slimming system
US20040086583A1 (en) *	2002-11-01	2004-05-06	Jensen Claude Jarakae	Anti-angiogenesis effects of morinda citrifolia

2004
- 2004-02-06 FI FI20040180A patent/FI121915B/fi not_active IP Right Cessation
2005
- 2005-02-04 PL PL05708155T patent/PL1718290T3/pl unknown
- 2005-02-04 US US10/588,051 patent/US20070258892A1/en not_active Abandoned
- 2005-02-04 EP EP05708155A patent/EP1718290B1/en not_active Expired - Lifetime
- 2005-02-04 CA CA2555328A patent/CA2555328C/en not_active Expired - Fee Related
- 2005-02-04 BR BRPI0507732-0A patent/BRPI0507732A/pt not_active IP Right Cessation
- 2005-02-04 WO PCT/FI2005/000075 patent/WO2005074910A1/en not_active Ceased
- 2005-02-04 ES ES05708155T patent/ES2344510T3/es not_active Expired - Lifetime
- 2005-02-04 DE DE602005021062T patent/DE602005021062D1/de not_active Expired - Lifetime
- 2005-02-04 PT PT05708155T patent/PT1718290E/pt unknown
- 2005-02-04 CN CN2005800041621A patent/CN1917868B/zh not_active Expired - Fee Related
- 2005-02-04 DK DK05708155.6T patent/DK1718290T3/da active
- 2005-02-04 JP JP2006551868A patent/JP4919812B2/ja not_active Expired - Fee Related
- 2005-02-04 AU AU2005210181A patent/AU2005210181B2/en not_active Ceased
- 2005-02-04 AT AT05708155T patent/ATE466576T1/de active
- 2005-02-04 RU RU2006128209/15A patent/RU2372899C2/ru not_active IP Right Cessation
2006
- 2006-09-04 NO NO20063937A patent/NO20063937L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1917868B (zh)	2010-09-01
PT1718290E (pt)	2010-07-01
RU2006128209A (ru)	2008-03-20
WO2005074910A1 (en)	2005-08-18
FI121915B (fi)	2011-06-15
HK1097455A1 (en)	2007-06-29
FI20040180L (fi)	2005-08-07
JP2007520532A (ja)	2007-07-26
FI20040180A0 (fi)	2004-02-06
DK1718290T3 (da)	2010-08-02
CA2555328A1 (en)	2005-08-18
ATE466576T1 (de)	2010-05-15
AU2005210181B2 (en)	2010-05-20
US20070258892A1 (en)	2007-11-08
ES2344510T3 (es)	2010-08-30
EP1718290B1 (en)	2010-05-05
JP4919812B2 (ja)	2012-04-18
BRPI0507732A (pt)	2007-07-10
AU2005210181A1 (en)	2005-08-18
EP1718290A1 (en)	2006-11-08
DE602005021062D1 (de)	2010-06-17
CN1917868A (zh)	2007-02-21
RU2372899C2 (ru)	2009-11-20
CA2555328C (en)	2013-03-26
PL1718290T3 (pl)	2010-10-29

Legal Events

Date	Code	Title	Description
2015-09-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20072542L (no)	2007-07-18	Pyrimidinderivat kondensert med ikke-aromatisk ring
WO2007061661A4 (en)	2009-01-29	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EA200602191A1 (ru)	2007-06-29	5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
NO20080284L (no)	2008-03-07	Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
NO20064584L (no)	2006-10-10	Tetrahydropyridoindolderivater
BRPI0418251C1 (pt)	2021-05-25	fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
SE0301010D0 (sv)	2003-04-07	Novel compounds
CL2008001839A1 (es)	2009-01-16	Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
NO20042596L (no)	2004-06-21	Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
NO20054769L (no)	2006-01-03	Substituerte fenylalkansyrer
NO20050932L (no)	2005-04-15	1-pyridin-4-yl-ureaderivater
SE0403006D0 (sv)	2004-12-09	New compounds
WO2007076085A3 (en)	2007-08-23	Fused pyrimidones and thiopyrimidones, and uses thereof
UA92348C2 (en)	2010-10-25	17b-HSD1 AND STS INHIBITORS
NO20063937L (no)	2006-09-04	Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis
ATE422201T1 (de)	2009-02-15	4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
BRPI0801239A2 (pt)	2009-11-17	uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
WO2007076087A3 (en)	2007-11-08	3-aryl-substituted quinazolones, and uses thereof
MX337606B (es)	2016-03-10	Metodo y composiciones farmaceuticas para el tratamiento de la hiperglicemia postprandial de la diabetes tipo ii, a traves de la mucosa bucal.
DE50312224D1 (de)	2010-01-21	Deuterierte catecholaminderivate sowie diese verbindungen enthaltende arzneimittel
TW200745081A (en)	2007-12-16	Compounds
NO20073710L (no)	2007-08-31	Kjemiske forbindelser
DK1824501T3 (da)	2009-12-21	Proteinhydrolysat med antidiabetisk virkning
TW200728281A (en)	2007-08-01	Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
DE602006008788D1 (de)	2009-10-08	Verbindungen